Danish Cancer Society-ko ikertzaileekin lankidetzan egindako argitalpenak (26)

2023

  1. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage

    Frontiers in Oncology, Vol. 13

  2. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 593-606

  3. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 580-592

2021

  1. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)

    Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776

2018

  1. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

    The Lancet, Vol. 391, Núm. 10125, pp. 1023-1075

2017

  1. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  2. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  3. Geographical variability in survival of European children with central nervous system tumours

    European Journal of Cancer, Vol. 82, pp. 137-148

2014

  1. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study

    The Lancet Oncology, Vol. 15, Núm. 1, pp. 23-34

2009

  1. Comparative cancer survival information in Europe

    European Journal of Cancer

  2. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 931-991

  3. Long-term survival expectations of cancer patients in Europe in 2000-2002

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 1028-1041

  4. Survival of European children and young adults with cancer diagnosed 1995-2002

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 992-1005

  5. Survival trends in European cancer patients diagnosed from 1988 to 1999

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 1042-1066

  6. The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 909-930

  7. The advantage of women in cancer survival: An analysis of EUROCARE-4 data

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 1017-1027

  8. The cure of cancer: A European perspective

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 1067-1079

2007

  1. Hepatocellular carcinoma: Trends of incidence and survival in Europe and the United States at the end of the 20th century

    American Journal of Gastroenterology, Vol. 102, Núm. 8, pp. 1661-1670

  2. Trends in cervical cancer survival in Europe, 1983-1994: A population-based study

    Gynecologic Oncology, Vol. 105, Núm. 3, pp. 609-619

2006

  1. Hodgkin disease survival in Europe and the U.S.: Prognostic significance of morphologic groups

    Cancer, Vol. 107, Núm. 2, pp. 352-360